Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Britain

- PMLiVE

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

Company says decision is not related to Brexit

- PMLiVE

UK bans some drug exports to preserve NHS stocks

Insists the move is not related to Brexit

- PMLiVE

Significant gaps remain in UK’s no-deal Brexit prep, says NAO report

Medicine supply still under threat despite preparedness programme

- PMLiVE

Johnson’s move to shorten Brexit debate faces backlash

Pharma opposed to no-deal, but backs pro-industry plans

- PMLiVE

Leaked no-deal Brexit document forecasts widespread shortages

Identifies risk of medicine shortages

- PMLiVE

Government to set up ‘express freight service’ for medicinal products in event of no-deal Brexit

Additional preparation to ensure continuity of supplies

- PMLiVE

Boris Johnson announces fast-track immigration plans for top scientists

Industry welcomes news but doubt over no-deal Brexit remains

- PMLiVE

Still no ferry contracts for no-deal Brexit medicines supplies

Major £434m set aside for medicines supplies, but time running out

- PMLiVE

UK sets aside £2.1bn for more no-deal Brexit prep

£434m for medicine continuity

- PMLiVE

Life sciences and NHS feature in Johnson speech – but Brexit promises predominate

GSK leader warns again on no-deal

- PMLiVE

Boris Johnson is new PM – but opposition to his Brexit plans mount

Brexit rhetoric unrealistic, suggests biotech leader

- PMLiVE

Prime minister contenders urged to embrace NHS-style social care funding

Will next PM face up to social care crisis?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links